Abstract
In an attempt to evaluate the influence of the GnRH analogue used during controlled ovarian hyperstimulation (COH) on the outcome of IVF cycles of polycystic ovary syndrome (PCOS) patients, we studied 152 IVF cycles. The PCOS patients undergoing COH using the GnRH agonist protocol (n = 50) showed a significantly higher pregnancy rate (36% vs. 19.6%, respectively), compared with the GnRH antagonist protocol (n = 102).
| Original language | English |
|---|---|
| Pages (from-to) | 1466-1468 |
| Number of pages | 3 |
| Journal | Fertility and Sterility |
| Volume | 91 |
| Issue number | 4 SUPPL. |
| DOIs | |
| State | Published - 1 Apr 2009 |
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver